Australian Rotavirus Surveillance Program annual report, 2013

Authors

  • Carl D Kirkwood Murdoch Childrens Research Institute, Parkville, Victoria
  • Susie Roczo-Farkas Murdoch Childrens Research Institute, Parkville, Victoria
  • Australian Rotavirus Surveillance Group

DOI:

https://doi.org/10.33321/cdi.2014.38.54

Keywords:

rotavirus, gastroenteritis, genotypes, disease surveillance

Abstract

This report from the Australian Rotavirus Surveillance Program, together with collaborating laboratories Australia-wide, describes the rotavirus genotypes responsible for the hospitalisation of children with acute gastroenteritis during the period 1 January to 31 December 2013. During the survey period, 1,035 faecal samples were referred for rotavirus G and P genotype analysis. Of these 828 were confirmed as rotavirus positive. A total of 503 specimens were collected from children under 5 years of age, while 325 were from older children and adults. Genotype analysis of the 828 rotavirus samples collected from both children and adults revealed that G12P[8] was the dominant genotype in this reporting period, identified in 33% of strains nationally. Genotype G3P[8] was the second most common strain nationally, representing 31% of samples, followed by genotype G2P[4] (14%). This represents the first report where G12P[8] strains are the major cause of disease in this population. The genotype distribution was slightly altered when the analysis was restricted to samples collected from children under 5 years of age, with G3P[8] being the dominant genotype (39.2%) followed by G12P[8] as the second most common genotype (31%). Fluctuations in genotype distribution were also observed based on the vaccine type in use. Genotype G12P[8] was more common in states and territories using RotaTeq, while G3P[8] was more common in the locations using Rotarix. This survey highlights the yearly fluctuations in rotavirus genotypes observed since vaccine introduction, with changes in dominant genotypes an annual event. The emergence of G12P[8] as the dominant genotype further illustrates the ongoing changes in the wild type rotavirus population evident in the Australian population since vaccine introduction. Commun Dis Intell 2014;38(4):E334–E342.

Downloads

Download data is not yet available.

References

Estes MK, Kapikian AZ. Rotviruses. In: Fields BN, Knipe DM, Howley PM, eds. Fields virology. 5th edn. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2007:1917–1974.

Parashar UD, Gibson CJ, Bresee JS, Glass RI. Rotavirus and severe childhood diarrhoea. Emerg Infect Dis 2006;12(2):304–306.

Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006;354(1):23–33.

Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006;354(1):11–22.

PATH – rotavirus vaccine access and delivery. [online]. Available from: http://sites.path.org/rotavirusvaccine/about-rotavirus/

Carlin J, Chondros P, Masendycz P, Bugg H, Bishop R, Barnes G. Rotavirus infection and rates of hospitalisation for acute gastroenteritis in young children in Australia, 1993–1996. Med J Aust 1998;169(5):252–256.

Dey A, Wang H, Menzies R, Macartney KK. Changes in hospitalisations for acute gastroenteritis in Australia after the national rotavirus vaccine program. Med J Aust 2012;197(8):453–457.

Buttery JP, Lambert SB, Grimwood K, Nissen MD, Field EJ, Macartney KK, et al. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia’s national childhood vaccine schedule. Pediatr Infect Dis J 2011;3(10):S25–S29.

Lambert SB, Faux CE, Hall L, Birrell FA, Peterson KV, Selvey CE. Early evidence for direct and indirect effects of the infant rotavirus vaccine program in Queensland. Med J Aust 2009;191(3):157–160.

Pendelton A, Galic M, Clarke C, Ng SP, Ledesma E, Ramakrishnan G, Liu Y. Impact of rotavirus vaccination in Australian children below 5 years of age. Human Vacc Immunoth 2013;9(8):1617–1625.

Kirkwood CD, Boniface K, Bogdanovic-Sakran N, Masendycz P, Barnes GL, Bishop RF. Rotavirus strain surveillance: An Australian perspective of strains causing disease in hospitalized children from 1997–2007. Vaccine 2009;27(5):F102–F107.

Gouvea V, Glass R, Woods P, Taniguchi K, Clark H, Forrester B, Fang Z. Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol 1990;28(2):276–282.

Gentsch JR, Glass RI, Woods P, Gouvea V, Gorziglia M, Flores J,et al. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol 1992;30(6):1365–1373.

Simmonds MK, Armah G, Asmah R, Banerjee I, Damanka S, Esona M, et al. New oligonucleotide primers for P-typing of rotavirus strains: Strategies for typing previously untypeable strains. J Clin Virol 2008;42(2):368–373.

Banerjee I, Ramani S, Primrose B, Iturriza-Gomara M, Gray JJ, Brown DW, et al. Modification of rotavirus multiplex RT-PCR for the detection of G12 strains based on characterization of emerging G12 rotavirus strains from South India. J Med Virol 2007;79(9):1413–1421.

Itturiza-Gomara M, Cubitt D, Desselberger U, Gray J. Amino acid substitution within the VP7 protein of G2 rotavirus strains associated with failure to serotype. J Clin Microbiol 2001;39(10):3796–3798.

Kirkwood CD, Cannan D, Boniface K, Bishop R, Barnes G. Australian rotavirus surveillance program, annual report, 2007/2008. Commun Dis Intell 2008;32(4):425–429.

Kirkwood CD, Boniface K, Bishop RF, Barnes GL. Australian Rotavirus Surveillance Program: annual report, 2009/2010. Commun Dis Intell 2010;34(4):427–434.

Kirkwood CD, Roczo S, Boniface K, Bishop RF, Barnes GL. Australian rotavirus surveillance program, annual report, 2010/2011. Commun Dis Intell 2011;35(4):281–287.

Kirkwood CD, Roczo-Farkas S, Bishop RF, Barnes GL. Australian rotavirus surveillance program, annual report, 2012. Commun Dis Intell 2014;38(1):E29–E35.

Banyai K, Laszlo B, Duque J, Steele AD, Nelson EAS, Gentsch JR, Parashar UD. Systematic review of regional and temporal trends in global rotavirus strains diversity in the pre-vaccine era: insights for understanding the impact of rotavirus vaccination programs. Vaccine 2012;30(suppl 1):A122–A130.

Page AL, Jusot V, Mamaty AA, Adamou L, Kaplon J, Pothier P, et al. Rotavirus surveillance in urban and rural areas of Niger, April 2010–March 2012. Emerg Infect Dis 2014;20(4):573-580.

Cilla G, Montes M, Gomariz M, Alkorta M, Iturzaeta A, Perez-Yarza EG, Perez-Trallero E. Rotavirus genotypes in children in the Basque Country (North of Spain): rapid and intense emergence of the G12[P8] genotype. Epidemiol Infect 2013;141(4):868–874.

Madhi SA, Cunliffe NA, Steele D, Witte D, Kirsten M, Louw C, Ngwira B, Victor JC, Gillard PH, Cheuvart BB, Han HH, Neuzil KM. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 2010;362(4):289–298.

Donato CM, Manuelpillai N, Roczo-Farkas S, Buttery JP, Crawford NW, Kirkwood CD. Genetic characterisation of a novel G3P[14] rotavirus strain causing severe gastroenteritis in 12 year old Australian child. Infect Gen Evol 2014;25:97–109.

Kirkwood CD, Boniface K, Barnes GL, Bishop RF. Distribution of rotavirus genotypes after introduction of rotavirus vaccines; Rotarix and RotaTeq into National Immunization Program of Australia. Ped Infect Dis 2011;30(1 suppl):S48–S53.

Downloads

Published

01/12/14

How to Cite

Kirkwood, Carl D, Susie Roczo-Farkas, and Australian Rotavirus Surveillance Group. 2014. “Australian Rotavirus Surveillance Program Annual Report, 2013”. Communicable Diseases Intelligence 38 (December):334-42. https://doi.org/10.33321/cdi.2014.38.54.

Most read articles by the same author(s)

1 2 > >>